natgillin/translations-raw huggingface dataset:
Ibandronic acid Sandoz 50 mg film-coated tablets ibandronic acid 
Ibandronska kislina Sandoz 50 mg filmsko obložene tablete ibandronska kislina
In particular, tell your doctor or pharmacist if you are taking any of the following medicines: supplements containing calcium, magnesium, iron or aluminium acetylsalicylic acid and non-steroidal anti-inflammatory medicines called “NSAIDs”, such as ibuprofen or naproxen. 
Svojemu zdravniku ali farmacevtu povejte še zlasti, če jemljete katero od naslednjih zdravil: • dodatke, ki vsebujejo kalcij, magnezij, železo ali aluminij,
Atypical fractures of the femur 
Atipični zlomi stegnenice
• severe adverse skin reactions 
• hudi neželeni učinki na koži.
- Water is the only drink that should be taken with Ibandronic acid Sandoz. 
Voda je edina tekočina, ki jo lahko bolnik zaužije z zdravilom Ibandronska kislina Sandoz.
Patients should receive supplemental calcium and/or vitamin D if dietary intake is inadequate. 
Za vse bolnike je pomemben zadosten vnos kalcija in vitamina D. Če je vnos s hrano nezadosten, morajo bolniki prejeti dodatke kalcija, vitamina D ali oboje.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. 
Druga zdravila in zdravilo Ibandronska kislina Sandoz Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
However, no dosage adjustment is required when ibandronic acid is administered with H2-antagonists or medicinal products that increase gastric pH. 
Pri sočasnem jemanju ibandronske kisline s H2-antagonisti ali zdravili, ki zvečajo pH želodca, pa prilagajanje odmerkov ni potrebno.
• if you are allergic to ibandronic acid or any of the other ingredients of this medicine that are listed in section 6 
Preobčutljivost na ibandronsko kislino ali katero koli pomožno snov, navedeno v poglavju 6.1.
Patients with disturbances of bone and mineral metabolism Hypocalcaemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Ibandronic acid Sandoz therapy. 
Pred začetkom zdravljenja z zdravilom Ibandronska kislina Sandoz je hipokalciemijo in druge motnje kosti in presnove mineralov treba učinkovito zdraviti.
NAME OF THE MEDICINAL PRODUCT Ibandronic acid Sandoz 50 mg film-coated tablets 
IME ZDRAVILA Ibandronska kislina Sandoz 50 mg filmsko obložene tablete
The start of treatment or of a new course of treatment should be delayed in patients with unhealed open soft tissue lesions in the mouth. 
Pri bolnikih z nezaceljenimi odprtimi lezijami mehkih tkiv v ustih je treba odložiti začetek zdravljenja ali začetek novega cikla zdravljenja.
Haemorrhage, duodenal ulcer, gastritis, dysphagia, dry mouth 
Bolezni prebavil ezofagitis, bolečina v trebuhu, dispepsija, navzea krvavitev, razjeda na dvanajstniku, gastritis, disfagija, suha usta
Ibandronic acid Sandoz contains the active substance ibandronic acid. 
Zdravilo Ibandronska kislina Sandoz vsebuje zdravilno učinkovino ibandronska kislina.
• if you cannot stand or sit upright for at least one hour (60 minutes) at a time 
Nezmožnost stanja ali pokončnega sedenja vsaj 60 minut.
What Ibandronic acid Sandoz contains - The active substance is ibandronic acid. 
Kaj vsebuje zdravilo Ibandronska kislina Sandoz - Zdravilna učinkovina je ibandronska kislina.
Cellulose, microcrystalline Crospovidone Maize starch pregelatinised Glycerol dibehenate Silica, anhydrous colloidal 
Jedro tablete: povidon mikrokristalna celuloza krospovidon koruzni škrob, predgelirani gliceroldibehenat brezvodni koloidni silicijev dioksid
Osteonecrosis of the jaw (ONJ) has been reported very rarely in the post marketing setting in patients receiving ibandronic acid for oncology indications (see section 4.8). 
Pri bolnikih, ki so prejemali ibandronsko kislino za indikacije v onkologiji, so v obdobju po prihodu zdravila na trg zelo redko poročali o osteonekrozi čeljusti (ONJ) (glejte poglavje 4.8).
Uncommon (may affect less than 1 in 100 people): 
Občasni (pojavijo se lahko pri manj kot 1 od 100 bolnikov)
Primary Efficacy Endpoints 
Primarni cilj raziskave učinkovitosti
QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 50 mg of ibandronic acid (as ibandronate sodium monohydrate). 
KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena filmsko obložena tableta vsebuje 50 mg ibandronske kisline (v obliki natrijevega ibandronata monohidrata).
A statistically significant improvement in bone pain score was shown for ibandronic acid 50 mg compared to placebo. 
V primerjavi s placebom se je pri ibandronski kislini v odmerku 50 mg pokazalo statistično značilno izboljšanje rezultata pri bolečinah v kosteh.
Each film-coated tablet contains 50 mg of ibandronic acid (as ibandronate sodium monohydrate). 
Vsaka filmsko obložena tableta vsebuje 50 mg ibandronske kisline (v obliki natrijevega ibandronata monohidrata).
Bioavailability was reduced by approximately 75% when ibandronic acid tablets were administered 2 hours after a standard meal. 
Ko so tablete ibandronske kisline dali 2 uri po standardnem obroku, se je biološka uporabnost zmanjšala za 75 %.
Acetylsalicylic acid and NSAIDs 
Acetilsalicilna kislina in nesteroidna protivnetna zdravila (NSAID)
What Ibandronic acid Sandoz looks like and contents of the pack The film-coated tablets are white, round biconvex tablets supplied in Polyamide/Al/PVC - Aluminum foil blister. 
Izgled zdravila Ibandronska kislina Sandoz in vsebina pakiranja Filmsko obložene tablete so bele, okrogle, bikonveksne tablete, na voljo v pretisnih omotih (poliamid/Al/PVC - aluminijasta folija), v pakiranjih po 3, 6, 9, 28 in 84 tablet.
Paraesthesia, dysgeusia (taste perversion) 
Bolezni živčevja parestezija, disgevzija (spremembe okušanja)
Keep taking Ibandronic acid Sandoz for as long as your doctor tells you. 
Če ste prenehali jemati zdravilo Ibandronska kislina Sandoz Zdravilo Ibandronska kislina Sandoz uporabljajte tako dolgo, kot vam naroči zdravnik.
A dental examination with preventive dentistry and an individual benefit-risk assessment is recommended prior to treatment with Ibandronic acid Sandoz in patients with concomitant risk factors. 
Pri bolnikih s spremljajočimi dejavniki tveganja je pred začetkom zdravljenja z zdravilom Ibandronska kislina Sandoz priporočljivo opraviti zobozdravniški pregled z ustreznimi preventivnimi zobozdravstvenimi ukrepi in oceniti razmerje med koristmi in tveganji pri vsakem posameznem bolniku.
How to take Ibandronic acid Sandoz 
Kako jemati zdravilo Ibandronska kislina Sandoz
Do not take your tablet with any drink other than water 
Tablete ne jemljite z nobenimi drugimi pijačami kot z vodo.
• if you have or ever had low calcium in your blood. 
• nizka raven kalcija v krvi;
No dosage adjustment is necessary for patients with mild renal impairment (CLcr ≥50 and <80 mL/min). 
Ledvična okvara Pri bolnikih z blago ledvično okvaro (CLcr ≥ 50 in < 80 ml/min) prilagajanje odmerka ni potrebno.
Azotaemia (uraemia) 
Bolezni sečil azotaemija (uremija)
The secretory pathway of renal elimination does not appear to include known acidic or basic transport systems involved in the excretion of other active substances In addition, ibandronic acid does not inhibit the major human hepatic P450 isoenzymes and does not induce the hepatic cytochrome P450 system in rats. 
Poleg tega ibandronska kislina pri ljudeh ne zavira glavnih jetrnih izoencimov P450, pri podganah pa ne spodbuja jetrnega sistema citokroma P450.
Cases of anaphylactic reaction/shock, including fatal events, have been reported in patients treated with intravenous ibandronic acid. 
Pri bolnikih, zdravljenih z intravensko ibandronsko kislino, so poročali o primerih anafilaktične reakcije/šoka, vključno s smrtnimi primeri.
• if you have any swallowing or digestion problems 
• če imate težave s požiranjem ali prebavo,
Your doctor may do regular blood tests while you are taking Ibandronic acid Sandoz. 
Morda bo zdravnik pri vas med jemanjem zdravila Ibandronska kislina Sandoz izvajal redne preglede krvi.
Each film-coated tablet contains 0.86 mg lactose (as lactose monohydrate). 
Pomožne snovi z znanim učinkom: ena filmsko obložena tableta vsebuje 0,86 mg laktoze (v obliki laktoze monohidrata).
There are no pharmacokinetic data for ibandronic acid in patients who have hepatic impairment. 
Pri bolnikih z jetrno okvaro za ibandronsko kislino ni farmakokinetičnih podatkov.
Table 1 Adverse Drug Reactions Reported for Oral Administration of Ibandronic acid System Organ 
Neželeni učinki zdravila, o katerih so poročali pri peroralnem dajanju ibandronske kisline
Medicinal products and supplements (including calcium) should similarly be avoided prior to taking Ibandronic acid Sandoz tablets. 
Pred jemanjem zdravila Ibandronska kislina Sandoz tablete se je prav tako treba izogibati jemanjem drugih zdravil in dodatkov (vključno s kalcijem).
Ocular inflammation events such as uveitis, episcleritis and scleritis have been reported with ibandronic acid. 
Z uporabo ibandronske kisline so poročali o primerih vnetja oči kot so uveitis, episkleritis in skleritis.
Musculoskeletal and connective tissue disorders 
Bolezni mišičnoskeletnega sistema in vezivnega tkiva atipični subtrohanterni in diafizealni stegneničnih zlomi†
How to store Ibandronic acid Sandoz 
Shranjevanje zdravila Ibandronska kislina Sandoz
A side effect called osteonecrosis of the jaw (ONJ) (bone damage in the jaw) has been reported very rarely in the post marketing setting in patients receiving ibandronic acid for cancer-related conditions. 
Pri bolnikih, ki so prejemali obandronsko kislino za zdravljenje bolezenskih stanj, povezanih z rakom, so v obdobju po prihodu zdravila na trg zelo redko poročali o neželenem učinku, imenovanem osteonekroza čeljusti (ONJ) (poškodba kosti v čeljusti).
Class 
Spol
Common (may affect up to 1 in 10 people): • feeling sick, heartburn and discomfort in swallowing (inflammation of your gullet/ food pipe) 
• slabost s siljenjem na bruhanje, zgaga in neprijeten občutek pri požiranju (vnetje požiralnika/grla).
- Patients should not lie down for 60 minutes after taking Ibandronic acid Sandoz. 
Po zaužitju zdravila Ibandronska kislina Sandoz bolniki 60 minut ne smejo leči.
It is important that you take Ibandronic acid Sandoz at the right time and in the right way. 
Pomembno je, da jemljete zdravilo Ibandronska kislina Sandoz ob pravem času in na pravi način, saj lahko povzroči draženje, vnetje ali razjede požiralnika/grla (ezofagusa).
STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 50 mg of ibandronic acid (as ibandronate sodium monohydrate). 
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena filmsko obložena tableta vsebuje 50 mg ibandronske kisline (v obliki natrijevega ibandronata monohidrata).
Hypocalcaemia** 
Presnovne in prehranske motnje hipokalciemija**
Renal impairment 
Draženje prebavil
This is because NSAIDs and Ibandronic acid Sandoz can both irritate your stomach and gut a type of antibiotic injection called “aminoglycoside” such as gentamicin. 
To je zato, ker lahko oboji, NSAID in zdravilo Ibandronska kislina Sandoz dražijo želodec in črevesje.
Metabolism and nutrition disorders 
Bolniki z motnjami kosti in presnove mineralov
Talk to your doctor or pharmacist before taking Ibandronic acid Sandoz • if you are allergic to any other bisphosphonates 
Pred začetkom jemanja zdravila Ibandronska kislina Sandoz se posvetujte z zdravnikom ali farmacevtom
Physicians should be alert to any signs or symptoms signaling a possible oesophageal reaction and patients should be instructed to discontinue Ibandronic acid Sandoz and seek medical attention if they develop dysphagia, odynophagia, retrosternal pain or new or worsening heartburn. 
Če se pri bolnikih med zdravljenjem z zdravilom Ibandronska kislina Sandoz pojavijo disfagija, bolečina pri požiranju, retrosternalna bolečina ali pojav ali poslabšanje zgage, morajo zdravljenje z zdravilom Ibandronska kislina Sandoz prekiniti in poiskati zdravniško pomoč.
Do not pass it on to others. 
Ne izzovite bruhanja.
- Abnormalities of the oesophagus which delay oesophageal emptying such as stricture or achalasia - Inability to stand or sit upright for at least 60 minutes - Hypocalcaemia - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 
Ne jemljite zdravila Ibandronska kislina Sandoz če ste alergični na ibandronsko kislino ali katero koli sestavino tega zdravila (navedeno v poglavju 6); če imate težave s požiralnikom/grlom (ezofagusom), kot so zoženje ali težave s požiranjem; če ne morete skupaj stati ali sedeti pokončno vsaj eno uro (60 minut); če imate ali ste kdaj imeli nizke koncentracije kalcija v krvi.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer Carton 
PODATKI NA ZUNANJI OVOJNINI Škatla
Do not take a double dose to make up for a forgotten dose. 
Če ste pozabili vzeti zdravilo Ibandronska kislina Sandoz Ne vzemite dvojnega odmerka, če ste pozabili vzeti prejšnji odmerek.
It does not matter whether you take it with or without food. 
Ni pomembno, ali jo vzamete s hrano ali brez nje.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 25 June 2015 
Datum prve odobritve: 25 junij 2015
Consequently, the frequency of these adverse events is qualified as “not known”. 
Zato je pogostnost teh neželenih učinkov opredeljena kot »neznana«.
• withdrawal symptoms in newborn babies in case of exposure during pregnancy, 
• odtegnitveni simptomi pri novorojenčkih v primeru izpostavljenosti zdravilu v času nosečnosti,
The treatment duration should be the minimum necessary for symptom control and must not exceed 12 weeks. 
Zdravljenje naj traja najkrajši čas, ki je potreben za obvladanje simptomov in ne sme trajati dlje kot 12 tednov.
• Unusual movements (especially of the face or tongue) and reduced level of consciousness. 
• nenavadne gibe (posebno v mišicah obraza ali jezika) in zmanjšano stopnjo zavesti.
Try to take Aripiprazole Zentiva at the same time each day. 
Prizadevajte si vzeti zdravilo Aripiprazol Zentiva vsak dan ob istem času.
In addition, cases of stroke or “mini” stroke have been reported. 
Poleg tega so poročali tudi o primerih možganske kapi ali "male" kapi.
Less than 1% of unchanged aripiprazole was excreted in the urine and approximately 18% was recovered unchanged in the faeces. 
Manj kot 1 % aripiprazola se je nespremenjenega izločilo v urinu in približno 18 % ga je bilo mogoče nespremenjenega najti v blatu.
• inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include: 
• nezmožnost upreti se impulzu, težnji ali skušnjavi po dejanjih, ki bi lahko škodila vam ali drugim, kot so:
Alternatively, disperse the tablet in water and drink the resulting suspension. 
Druga možnost je, da tableto raztopite v vodi in popijete nastalo suspenzijo.
• difficulty sleeping, 
• težave s spanjem,
Blood pressure-lowering medicines: Aripiprazole Zentiva may increase the effect of medicines used to lower the blood pressure. 
Zdravila za zniževanje krvnega tlaka: zdravilo Aripiprazol Zentiva lahko okrepi učinek zdravil, ki se uporabljajo za zniževanje krvnega tlaka.
The absolute oral bioavailability of the tablet formulation is 87%. 
Absolutna peroralna biološka uporabnost zdravila v tabletah je 87 %.
Aripiprazole Zentiva with food, drink and alcohol This medicine can be taken regardless of meals. 
Zdravilo Aripiprazol Zentiva skupaj s hrano, pijačo in alkoholom To zdravilo lahko jemljete ne glede na obroke.
If you are an elderly patient suffering from dementia (loss of memory and other mental abilities), you or your carer/relative should tell your doctor if you have ever had a stroke or “mini” stroke. 
Če ste starejša oseba in imate demenco (slabšanje spomina in drugih duševnih sposobnosti), morate vi ali vaš skrbnik/sorodnik zdravniku povedati, če ste kdaj imeli možgansko kap ali "malo" kap.
Even if you feel better, do not alter or discontinue the daily dose of Aripiprazole Zentiva without first consulting your doctor. 
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila Aripiprazol Zentiva, ne da bi se prej posvetovali z zdravnikom.
• past experience with excessive gambling. 
• ste kdaj imeli težave s pretiranim hazardiranjem.
If you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day. 
Če ste pozabili vzeti zdravilo Aripiprazol Zentiva Če ste pozabili vzeti odmerek, ga vzemite takoj, ko se spomnite, vendar ne vzemite dveh odmerkov na en dan.
Pharmacotherapeutic group: Psycholeptics, other antipsychotics, ATC code: N05AX12 
Farmakoterapevtska skupina: psiholeptiki, drugi antipsihotiki, oznaka ATC: N05AX12
Activated charcoal (50 g), administered one hour after aripiprazole, decreased aripiprazole Cmax by about 41% and AUC by about 51%, suggesting that charcoal may be effective in the treatment of overdose. 
Aktivno oglje (50 g), uporabljeno eno uro po aripiprazolu, je zmanjšalo Cmax aripiprazola za približno 41 % in AUC za približno 51 %, kar kaže, da bi bilo oglje lahko učinkovito za zdravljenje prevelikega odmerjanja.
The highest nontumorigenic exposure in female rats was 7 times the human exposure at the recommended dose. 
Največja netumorogena izpostavljenost samic podgan je bila 7krat večja od izpostavljenosti človeka pri priporočenem odmerku.
Aripiprazole Zentiva is effective in a dose range of 10 to 30 mg/day. 
Zdravilo Aripiprazol Zentiva je učinkovito v razponu odmerkov od 10 do 30 mg/dan.
At therapeutic concentrations, aripiprazole and dehydro-aripiprazole are greater than 99% bound to serum proteins, binding primarily to albumin. 
V terapevtskih koncentracijah je več kot 99 % aripiprazola in dehidroaripiprazola vezanega na beljakovine v serumu, predvsem na albumin.
Following a single oral dose of [14C]-labelled aripiprazole, approximately 27% of the administered radioactivity was recovered in the urine and approximately 60% in the faeces. 
Po enem samem peroralnem odmerku aripiprazola, označenega s [14C], se je približno 27 % aplicirane radioaktivnosti pojavilo v urinu in približno 60 % v blatu.
The point estimate of the hazard ratio (HR) was 0.461 (95% confidence interval, 0.242 - 0.879) in the full population. 
Ocenjena vrednost razmerja ogroženosti (RO) je bila 0,461 (95-% interval zaupanja, 0,242-0,879) pri celotni poulaciji.
The European Medicines Agency has deferred the obligation to submit the results of studies with the reference medicinal product containing aripiprazole in one or more subsets of the paediatric population in the treatment of schizophrenia and in the treatment of bipolar affective disorder (see section 4.2 for information on paediatric use). 
Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij z referenčnim zdravilom, ki vsebuje aripiprazol za eno ali več podskupin pediatrične populacije pri zdravljenju shizofrenije in bipolarne afektivne motnje (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
• thoughts of suicide, suicide attempt and suicide; 
• povečanje telesne mase, • misli na samomor, poskus samomora in samomor,
In a sub-analysis of the adolescent patients between the ages of 15 to 17 years, representing 74% of the total enrolled population, maintenance of effect was observed over the 26-week open-label extension trial. 
Pri analizi podskupine mladostnikov, starih od 15 do 17 let, ki je obsegala 74 % vseh vključenih bolnikov, se je učinek ohranil ves čas 26-tedenskega odprtega podaljšanega preskušanja.
Manufacturer S.C. Zentiva S.A. 
Izdelovalec S.C. Zentiva S.A.
• Certain antibiotics used to treat tuberculosis (rifabutin, rifampicin) 
• določene antibiotike, ki se uporabljajo za zdravljenje tuberkoloze (rifabutin, rifampicin).
The overall completion rate was significantly higher for patients on aripiprazole (43%) than for haloperidol (30%). 
Celotni delež dokončanja je bil pri bolnikih, ki so dobivali aripiprazol, značilno večji (43 %) kot pri tistih, ki so dobivali haloperidol (30 %).
• blood clots in the veins, especially in the legs (symptoms include swelling, pain and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing (if you notice any of these symptoms, seek medical advice immediately), 
• krvni strdki v venah, zlasti v venah nog (simptomi vključujejo oteklino, bolečino in rdečino noge), ki lahko potujejo po krvnih žilah v pljuča in povzročijo bolečino v prsih in težave z dihanjem (če opazite katerega od navedenih simptomov, takoj poiščite zdravniško pomoč),
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. 
Druga zdravila in zdravilo Aripiprazol Zentiva Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo, vključno z zdravili, ki ste jih dobili brez recepta.
In the same trials, cerebrovascular adverse reactions (e.g. stroke, transient ischaemic attack), including fatalities, were reported in patients (mean age: 84 years; range: 78 - 88 years). 
V istih preskušanjih so poročali o cerebrovaskularnih neželenih učinkih (npr. možganski kapi, prehodnem ishemičnem napadu), vključno s smrtnimi primeri (povprečna starost bolnikov: 84 let, razpon: 78-88 let).
However, the estimation of the HR for the younger (13 - 14 years) group was not precise, reflecting the smaller number of subjects in that group (aripiprazole, n = 29; placebo, n = 12), and the confidence interval for this estimation (ranging from 0.151 to 1.628) did not allow conclusions to be drawn on the presence of a treatment effect. 
Vendar pa ocena razmerja ogroženosti pri skupini mlajših mladostnikov (13-14 let) ni bila točna zaradi manjšega števila preskušancev v tej skupini (aripiprazol, n = 29; placebo, n = 12), interval zaupanja za to oceno (ki je od 0,151 do 1,628) pa ne omogoča zaključkov o prisotnosti učinka zdravljenja.
Aripiprazole Zentiva contains the active substance aripiprazole and belong to a group of medicines called antipsychotics. 
Zdravilo Aripiprazol Zentiva vsebuje učinkovino aripiprazol in spada v skupino zdravil, imenovanih antipsihotiki.
The score line is not intended for breaking the tablet. 
Zareza ni namenjena delitvi tablete.
• Rapid heartbeat, agitation/aggressiveness, problems with speech. 
• hitro bitje srca, vznemirjenost/agresivnost, težave pri govoru;
14 tablets 28 tablets 49 tablets 56 tablets 98 tablets 
14 tablet 28 tablet 49 tablet 56 tablet 98 tablet
All ADRs are listed by system organ class and frequency; very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000) and not known (cannot be estimated from the available data). 
pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) in neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
Taking Aripiprazole Zentiva with some medicines may mean the doctor will need to change your dose of Aripiprazole Zentiva or the other medicines. 
Če jemljete zdravilo Aripiprazol Zentiva z nekaterimi drugimi zdravili, bo morda zdravnik moral spremeniti vaš odmerek zdravila Aripiprazol Zentiva ali drugih zdravil.
In a haloperidol-controlled trial, the proportion of responder patients maintaining response to medicinal product at 52-weeks was similar in both groups (aripiprazole 77% and haloperidol 73%). 
V preskušanju, nadzorovanem s haloperidolom, je bil delež odzivnih bolnikov, pri katerih se je odziv na zdravilo ohranil po 52 tednih, v obeh skupinah podoben (aripiprazol 77 % in haloperidol 73 %).
Aripiprazole is well absorbed, with peak plasma concentrations occurring within 3 - 5 hours after dosing. 
Aripiprazol se dobro absorbira in doseže največjo koncentracijo v plazmi v 3 do 5 urah po uporabi.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially “sodium free”. 
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na tableto, kar v bistvu pomeni ‘brez natrija' .